Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC415

Capmatinib eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    14.12.2022
  • Application published:
    15.1.2023
  • Grant published:
    15.9.2024
  • Max expiry date:
    18.11.2032
  • Medicine name:
    Tabrecta
  • Medicine for children:
    No

Timeline

Today
14.12.2022Application
15.1.2023Publication
15.9.2024Registration
18.11.2032Expires

Marketing license

  • IS authorization number:
    EU/1/22/1650
  • Date:
    12.7.2022
  • Foreign authorization number:
    EU/1/22/1650
  • Date:
    20.6.2022

Owner

  • Name:
    Incyte Holdings Corporation
  • Address:
    1801 Augustine Cut-Off, Wilmington US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 16.09.2024

Upload documents